Filing Flows › Paysign (PAYS) › Pharma Industry revenue
Paysign (PAYS) Pharma Industry revenue by quarter
Paysign's Pharma Industry revenue was $14.6M in Q2 2026 (second quarter 2026), -7% from Q1 2026. Over the last 6 quarters it ranged from $7.8M (Q2 2025) to $15.7M (Q1 2026).
| Quarter | Pharma Industry revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $14.6M | -7% | +89% |
| Q1 2026 | $15.7M | +63% | +82% |
| Q4 2025 | $9.6M | +21% | — |
| Q3 2025 | $7.9M | +2% | — |
| Q2 2025 | $7.8M | -10% | — |
| Q1 2025 | $8.6M | — | — |
Q2 2026 at a glance
Paysign, Q2 2026: revenue $28.3M (+48% year over year), operating margin 24.8%, net earnings $6.8M, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Paysign's Pharma Industry revenue?
Paysign's Pharma Industry revenue was $14.6M in Q2 2026 (second quarter 2026), -7% from Q1 2026.
How has Paysign's Pharma Industry revenue changed?
Over the last 6 quarters it ranged from $7.8M (Q2 2025) to $15.7M (Q1 2026).